Videos

8:06

Medical oncologist Mark Kris says that choosing the right medicine for non-small lung cancer at time of diagnosis is key to getting the best result.

1:58

Godine Weiss. After 2 years of Issels Treatment PET and CT scans of December 2007 show lung tumor now only scar tissue, lymph metastases smaller and tumor marker normal. March 2008, Godine is in good condition and continues to be involved in many activities. March 2009, Godine is in good condition and great spirits.

The Issels Treatment is a comprehensive immunotherapy program that integrates the most effective state-of-the-art technologies, such as advanced cancer vaccines, and other safe and scientifically validated therapies. For more information on the Issels Treatment, please visit http://www.issels.com or call 1.888.447.7357.

3:03

Check out my videos in 1080p HD - https://vimeo.com/johnferaco Filmed, Produced and Edited by John Feraco. Elizabeth R Woods Foundation - Non-Small Cell Lung Cancer How the foundation originated, their goals and the importance of their efforts.

3:11

If you like this animation, LIKE us on Facebook: http://www.nucleusinc.com/facebook http://www.nucleusinc.com/medical-animation This 3D medical animation begins with a detailed description of the staging or progression of the lung cancer. It describes the occult stage where cancer cells are in the body fluid but no tumor can be seen in the lungs. Stage 0 occurs when cancer cells are found in the airway lining. It goes to demonstrate Stage IA, IB, IIA, IIB which are considered invasive and the cancer cells have invaded the airway lining.

3:31

Interview with David Ross Camidge, MD, PhD, Assistant Professor, University of Colorado, Denver, Colorado, USA Non-small cell lung cancer is currently the single biggest killer from cancer of any disease in the world. It's called non-small cell lung cancer to distinguish it from another rarer type of lung cancer called small cell, which behaves very differently and is treated very differently. Professor Thomas J. Lynch, MD, Director of Yale Cancer Centre, discusses the oral, once daily investigational targeted therapy Afatinib, and the impact it could have for patients with non-small cell lung cancer who have the EGFR mutation. If you are a journalist and would like more information please visit: http://www.newshome.com/oncology/ If you are a healthcare professional and would like more information please visit: http://www.inoncology.com/

0:00

mesothelioma,mesothelioma symptoms,mesothelioma lawyer,lawyer mesothelioma,what is mesothelioma,mesothelioma settlements,mesothelioma survivors,virginia mesothelioma lawyers,california,colorado,florida,lawyers,mesothelioma pleural,mesothelioma law,mesothelioma attorney,abdominal mesothelioma,about mesothelioma,abspestos,advanced mesothelioma,alternative mesothelioma treatment,asbestos and cancer,asbestos and lung cancer,asbestos and mesothelioma,asbestos attorney,asbestos attorney mesothelioma,asbestos attorneys,asbestos cancer,asbestos cancer attorney,asbestos cancer lawsuit,asbestos cancer mesothelioma,asbestos cancer mesothelioma,asbestos mesothelioma cancer,cancer and mesothelioma,cancer lung mesothelioma,cancer mesothelioma,is mesothelioma cancer,lung cancer and mesothelioma,lung cancer mesothelioma,mesothelioma and lung cancer,mesothelioma asbestos cancer,attorney lawyer mesothelioma,best mesothelioma lawyers,dallas mesothelioma lawyer,del

9:38

Bill McQueen was diagnosed with mesothelioma in 2011. The Wall Street Journal spent a year with the Texas surgeon and his family as they battled this fatal disease. Click here to subscribe to our channel: ‪http://bit.ly/14Q81Xy‬ Visit us on Facebook: http://www.facebook.com/wsjlive Follow us on Twitter: https://twitter.com/WSJLive Visit the Wall Street Journal: www.wsj.com

4:00

This is my personal story of my journey with Mesothelioma. There are still people who believe asbestos is not a threat. This is just one person, that is one too many.